The associations of two SNPs in miRNA-146a and one SNP in ZBTB38-RASA2 with the disease susceptibility and the clinical features of the Chinese patients of sCJD and FFI

References

• Prusiner SB. Prions. Proc Natl Acad Sci U S A. 1998;95(23):13363–83. doi:10.1073/pnas.95.23.13363.
   PubMed Web of Science ®Google Scholar
• Chen C, Dong XP. Epidemiological characteristics of human prion diseases. Infect Dis Poverty. 2016;5(1):47. doi:10.1186/s40249-016-0143-8.
   PubMedGoogle Scholar
• Jeong BH, Kim YS. Genetic studies in human prion diseases. J Korean Medical Sci. 2014;29(5):623–32. doi:10.3346/jkms.2014.29.5.623.
   PubMed Web of Science ®Google Scholar
• Lloyd SE, Mead S, Collinge J. Genetics of prion diseases. Curr Opin Genetics Dev. 2013;23(3):345–51. doi:10.1016/j.gde.2013.02.012.
   PubMed Web of Science ®Google Scholar
• Boon LM, Mulliken JB, Vikkula M. RASA1: variable phenotype with capillary and arteriovenous malformations. Curr Opin Genetics Dev. 2005;15(3):265–9. doi:10.1016/j.gde.2005.03.004.
   PubMed Web of Science ®Google Scholar
• Mead S, Uphill J, Beck J, et al. Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP. Hum Mol Genetics. 2012;21(8):1897–906. doi:10.1093/hmg/ddr607.
   PubMed Web of Science ®Google Scholar
• O'Neill LA, Sheedy FJ, McCoy CE. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol. 2011;11(3):163–75. doi:10.1038/nri2957.
   PubMed Web of Science ®Google Scholar
• Taganov KD, Boldin MP, Chang KJ, et al. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006;103(33):12481–6. doi:10.1073/pnas.0605298103.
   PubMed Web of Science ®Google Scholar
• Alexandrov PN, Dua P, Lukiw WJ. Up-regulation of miRNA-146a in progressive, age-related inflammatory neurodegenerative disorders of the human CNS. Frontiers Neurol. 2014;5:181. doi:10.3389/fneur.2014.00181.
   PubMed Web of Science ®Google Scholar
• Devier DJ, Lovera JF, Lukiw WJ. Increase in NF-kappaB-sensitive miRNA-146a and miRNA-155 in multiple sclerosis (MS) and pro-inflammatory neurodegeneration. Frontiers Mol Neurosci. 2015;8:5. doi:10.3389/fnmol.2015.00005.
   PubMed Web of Science ®Google Scholar
• Zhang B, Wang A, Xia C, et al. A single nucleotide polymorphism in primary-microRNA-146a reduces the expression of mature microRNA-146a in patients with Alzheimer's disease and is associated with the pathogenesis of Alzheimer's disease. Mol Med Reports. 2015;12(3):4037–42. doi:10.3892/mmr.2015.3968.
   PubMed Web of Science ®Google Scholar
• Li X, Li K, Wu Z. Association of four common SNPs in microRNA polymorphisms with the risk of hepatocellular carcinoma. Int J Clin Exp Pathol. 2015;8(8):9560–6.
   PubMed Web of Science ®Google Scholar
• Zerr I, Poser S. Clinical diagnosis and differential diagnosis of CJD and vCJD. With special emphasis on laboratory tests. APMIS: Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. 2002;110(1):88–98. doi:10.1034/j.1600-0463.2002.100111.x.
   PubMed Web of Science ®Google Scholar
• Gao C, Shi Q, Tian C, et al. The epidemiological, clinical, and laboratory features of sporadic Creutzfeldt-Jakob disease patients in China: surveillance data from 2006 to 2010. PloS One. 2011;6(8):e24231. doi:10.1371/journal.pone.0024231.
   PubMed Web of Science ®Google Scholar
• Shi Q, Zhou W, Chen C, et al. The features of genetic prion diseases based on Chinese Surveillance program. PloS One. 2015;10(10):e0139552. doi:10.1371/journal.pone.0139552.
   PubMed Web of Science ®Google Scholar
• Shi Q, Zhou W, Chen C, et al. Quality evaluation for the surveillance system of human prion diseases in China based on the data from 2010 to 2016. Prion. 2016;10(6):484–491. doi:10.1080/19336896.2016.1229731.
   PubMed Web of Science ®Google Scholar
• Colby DW, Prusiner SB. De novo generation of prion strains. Nat Rev Microbiol. 2011;9(11):771–7. doi:10.1038/nrmicro2650.
   PubMed Web of Science ®Google Scholar
• Lukiw WJ, Dua P, Pogue AI, et al. Upregulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker (GSS) syndrome. J Toxicol Environmental Health Part A. 2011;74(22–24):1460–8. doi:10.1080/15287394.2011.618973.
   PubMed Web of Science ®Google Scholar
• Luo X, Yang W, Ye DQ, et al. A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genetics. 2011;7(6):e1002128. doi:10.1371/journal.pgen.1002128.
   PubMed Web of Science ®Google Scholar
• Saba R, Gushue S, Huzarewich RL, et al. MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state. PloS One. 2012;7(2):e30832. doi:10.1371/journal.pone.0030832.
   PubMed Web of Science ®Google Scholar
• Lv Y, Chen C, Zhang BY, et al. Remarkable activation of the complement system and aberrant neuronal localization of the membrane attack complex in the brain tissues of Scrapie-Infected Rodents. Mol Neurobiol. 2015;52(3):1165–1179. doi:10.1007/s12035-014-8915-2.
   PubMed Web of Science ®Google Scholar
• Cui L, Li Y, Ma G, et al. A functional polymorphism in the promoter region of microRNA-146a is associated with the risk of Alzheimer disease and the rate of cognitive decline in patients. PloS One. 2014;9(2):e89019. doi:10.1371/journal.pone.0089019.
   PubMed Web of Science ®Google Scholar
• Strauss KI, Barbe MF, Marshall RM, et al. Prolonged cyclooxygenase-2 induction in neurons and glia following traumatic brain injury in the rat. J Neurotrauma. 2000;17(8):695–711. doi:10.1089/089771500415436.
   PubMed Web of Science ®Google Scholar